Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Mehran

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Scientific Reports|November 16, 2016
TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinCao Xiaobo, Mourad Majidi, Meng Feng, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 25, 2021
Intraoperative Dexmedetomidine and Ketamine Infusions in an Enhanced Recovery After Thoracic Surgery Program: A Propensity Score Matched AnalysisGabriel E Mena, Andres Zorrilla-Vaca, Ara Vaporciyan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2014
Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapyTommy Sheu, John V Heymach, Stephen G Swisher, et al.
The Annals of Thoracic Surgery|April 13, 2025
Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer PatientsZamaan Hooda, Zhigang Duan, Shanique Ries, et al.
Surgery|November 6, 2021
Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear modelAndres Zorrilla-Vaca, David Rice, Jessica K Brown, et al.
The Annals of Thoracic Surgery|December 16, 2014
Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for managementMin P Kim, Arlene M Correa, Wayne Hofstetter, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone"Joe Y Chang, Qiao-Qiao Li, Qing-Yong Xu, et al.
Cancer Research|March 15, 2014
Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacyReza Mehran, Monique Nilsson, Mehrdad Khajavi, et al.
The American Surgeon|August 7, 2009
Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancerWilliam D Bolton, David C Rice, Arlene M Correa, et al.
Annals of Diagnostic Pathology|April 22, 2014
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaAnne S Tsao, Nusrat Harun, Junya Fujimoto, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Scientific Reports|November 16, 2016
TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinCao Xiaobo, Mourad Majidi, Meng Feng, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 25, 2021
Intraoperative Dexmedetomidine and Ketamine Infusions in an Enhanced Recovery After Thoracic Surgery Program: A Propensity Score Matched AnalysisGabriel E Mena, Andres Zorrilla-Vaca, Ara Vaporciyan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2014
Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapyTommy Sheu, John V Heymach, Stephen G Swisher, et al.
The Annals of Thoracic Surgery|April 13, 2025
Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer PatientsZamaan Hooda, Zhigang Duan, Shanique Ries, et al.
Surgery|November 6, 2021
Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear modelAndres Zorrilla-Vaca, David Rice, Jessica K Brown, et al.
The Annals of Thoracic Surgery|December 16, 2014
Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for managementMin P Kim, Arlene M Correa, Wayne Hofstetter, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone"Joe Y Chang, Qiao-Qiao Li, Qing-Yong Xu, et al.
Cancer Research|March 15, 2014
Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacyReza Mehran, Monique Nilsson, Mehrdad Khajavi, et al.
The American Surgeon|August 7, 2009
Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancerWilliam D Bolton, David C Rice, Arlene M Correa, et al.
Annals of Diagnostic Pathology|April 22, 2014
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaAnne S Tsao, Nusrat Harun, Junya Fujimoto, et al.
Pageof 7